Showing results (1-10 of 3,903) with videos related to
Sort By:
Pageof 391
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|November 29, 2015
HER2/ERBB2 immunoreactivity in human retinoblastomaG M Seigel, S Sharma, A S Hackam, et al.Journal of Pharmacokinetics and Pharmacodynamics|September 17, 2015
Pharmacokinetic and pharmacodynamic considerations for the next generation protein therapeuticsDhaval K ShahJournal of Pharmacokinetics and Pharmacodynamics|September 3, 2020
Development of a physiologically-based pharmacokinetic model for ocular disposition of monoclonal antibodies in rabbitsDavid Bussing, Dhaval K ShahThe AAPS Journal|April 28, 2023
Physiologically Based Pharmacokinetic Modeling to Characterize the Effect of Molecular Charge on Whole-Body Disposition of Monoclonal AntibodiesShufang Liu, Dhaval K ShahAntibodies (Basel, Switzerland)|April 23, 2025
Effect of Acute Lung Injury (ALI) Induced by Lipopolysaccharide (LPS) on the Pulmonary Pharmacokinetics of an AntibodyShweta Jogi, Dhaval K ShahDrug Metabolism and Disposition: the Biological Fate of Chemicals|February 24, 2022
Mathematical Models to Characterize the Absorption, Distribution, Metabolism, and Excretion of Protein TherapeuticsShufang Liu, Dhaval K ShahJournal of Pharmacokinetics and Pharmacodynamics|April 28, 2019
Two-pore physiologically based pharmacokinetic model with de novo derived parameters for predicting plasma PK of different size protein therapeuticsZhe Li, Dhaval K ShahMethods in Molecular Biology (Clifton, N.J.)|October 24, 2019
Determination of ADC Cytotoxicity in Immortalized Human Cell LinesShengjia Wu, Dhaval K ShahAntibodies (Basel, Switzerland)|February 21, 2025
Investigation of Antibody Pharmacokinetics in Male Reproductive System and Its Characterization Using a Translational PBPK ModelSree Ojili, Dhaval K ShahDrug Metabolism and Disposition: the Biological Fate of Chemicals|August 20, 2017
Measurement and Mathematical Characterization of Cell-Level Pharmacokinetics of Antibody-Drug Conjugates: A Case Study with Trastuzumab-vc-MMAEAman P Singh, Dhaval K ShahPageof 391